Listed

NEUROONE MEDICAL TECHNOLOGIES Corp: Form 10-Q for the period ended Dec 31, 2022

Filed with the SEC on Feb 13, 2023 and accepted by EDGAR at Feb 13, 2023, 21:15 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2022-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2022-10-01 to 2022-12-31$114.6kus-gaap:Revenues
Cost of revenue3 months2022-10-01 to 2022-12-31$126.9kus-gaap:CostOfRevenue
Gross profit3 months2022-10-01 to 2022-12-31−$12.3kus-gaap:GrossProfit
Research and development3 months2022-10-01 to 2022-12-31$1.6mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2022-10-01 to 2022-12-31$1.7mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2022-10-01 to 2022-12-31−$1.8mus-gaap:OperatingIncomeLoss
Net income3 months2022-10-01 to 2022-12-31−$1.7mus-gaap:NetIncomeLoss
Diluted EPS3 months2022-10-01 to 2022-12-31−$0.11us-gaap:EarningsPerShareDiluted
Basic EPS3 months2022-10-01 to 2022-12-31−$0.11us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2022-10-01 to 2022-12-3116,230,997 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2022-10-01 to 2022-12-31−$3.5mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2022-10-01 to 2022-12-31$11.5kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2022-12-31$4.7mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2022-12-31$9.0mus-gaap:AssetsCurrent
Total assetsAt period end2022-12-31$9.7mus-gaap:Assets
Current liabilitiesAt period end2022-12-31$1.3mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2022-12-31$1.5mus-gaap:Liabilities
Shareholders' equityAt period end2022-12-31$8.2mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001213900-23-010739. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.